catalogue
Metabolic Dominionavailable
TRINITY RT3
Retatrutide is a multi-receptor agonist targeting GLP-1, GIP, and glucagon receptors. It is studied for its role in complex metabolic signaling, including receptor co-activation and cAMP-mediated intracellular pathways.
$135.0020 mg
Account and destination review required before payment. US shipping only.
Research use only. Not for human or veterinary use.
product overview
Description
Retatrutide is a multi-receptor agonist targeting GLP-1, GIP, and glucagon receptors. It is studied for its role in complex metabolic signaling, including receptor co-activation and cAMP-mediated intracellular pathways. For research use only. Not for human consumption.
Current package: 20 mg. Form: Laboratory research material.
record / specification
Material data
- Category
- Metabolic Dominion
- Availability
- available
- SKU
- DC-RT3-20
- Active lot
- Pending assignment
- Package
- 20 mg
- Form
- Laboratory research material
- SKU
- DC-RT3-20
- Storage
- See supplied handling sheet
- Documentation
- Available by lot
lot document
Demonstration certificate / PDF